Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ron Bentsur currently holds 3,525,924 shares of XTL BIOPHARMACEUTICALS LTD (XTLB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ron Bentsur has been a net seller of XTLB stock. They have purchased $2.6M and sold $13.6M worth of shares.
Ron Bentsur's most recent insider trade was on Nov 5, 2025, when they purchased 5,000 shares at $5.72 per share.
Ron Bentsur serves as Executive at XTL BIOPHARMACEUTICALS LTD (XTLB). They have executed 188 insider transactions totaling $16.2M over their tenure at the company.
Ron Bentsur holds the position of Executive at XTL BIOPHARMACEUTICALS LTD, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Ron Bentsur has shown a selling trading pattern, with $2.6M in total purchases and $13.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ron Bentsur was on Mar 18, 2024, when they purchased $51.5K worth of NVCT shares. This transaction involved 5,000 shares at $10.29 per share.
Ron Bentsur currently owns 3,525,924 shares of XTL BIOPHARMACEUTICALS LTD (XTLB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ron Bentsur's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ron Bentsur has 188 Form 4 filings on record as an insider at XTL BIOPHARMACEUTICALS LTD.
Set alerts for Ron Bentsur and 40,000+ other insiders.